期刊文献+

乳腺癌组织中Id1基因mRNA的表达及其与临床病理的关系 被引量:1

Id1 mRNA Expression in Breast Cancer and Its Relation to Clinicopathological Features
下载PDF
导出
摘要 目的观察乳腺癌组织中的分化/DNA结合抑制因子1(Id1)mRNA表达情况,并探讨其与临床病理及其他分子指标的关系。方法应用实时荧光定量逆转录——聚合酶链反应对48例乳腺癌组织,20例乳腺纤维腺瘤组织及乳腺癌MCF-7细胞系中Id1mRNA进行检测。以免疫组织化学SABC法检测Id1蛋白在乳腺癌、乳腺纤维腺瘤组织中的表达及与乳腺癌中VEGF蛋白表达的关系。结果经实时荧光定量RT-PCR法检测,乳腺癌组织,乳腺纤维腺瘤组织中的2-ΔCT值分别为:(3.4581±1.3644)、(1.1042±0.0125)。乳腺癌组织的Id1mRNA阳性表达率均显著高于乳腺纤维腺瘤组织(P<0.05),Spearman等级相关分析表明其与VEGF表达呈正相关(r=0.303,P=0.037)。而与患者的年龄,淋巴结转移,肿块大小、组织学分级,pTNM分期等临床病理因素无关(P>0.05)。结论 Id1在乳腺癌中高表达,与VEGF表达呈正相关,可能与血管形成有关。 Objective To investigate the expression of inhibitor of differentiation/DNA binding 1(Id1) in breast cancer tissue and its relation to clinicopathological and other molecular parameters.Methods The mRNA expression of Id1 in tissue and MCF-7 cell line of breast cancer were detected by fqRT-PCR.The protein expression of Id1,VEGF in 48 cases of breast carcinoma and 20 cases of breast fibroadenoma tissues of breast were detected by SABC immunohistochemistry.Results By Real-time RT-PCR method,the 2-ΔCT values of the breast carcinoma tissue and breast fibroadenoma tissue were(3.4581±1.3644) and(1.1042±0.0125) respectively.The positive rates of Id1 were significantly higher in breast carcinoma than those in breast fibroadenoma tissues,there were significant difference between the two groups(P0.05).Spearman rank correlation analysis revealed that the protein expression of Id1 was positively correlated with that of VEGF(r=0.303,P=0.037).No statistical correlation existed among the patients as grouped by age,lymph nodes metastasis,tumor size,histological grading,pTNM stages(P0.05).Conclusion Over-expression of Id1 exists in the patients with breast cancer.The expression of Id1 is positively correlated with that of VEGF which may be related to blood vessel formation.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第7期780-783,共4页 Cancer Research on Prevention and Treatment
基金 唐山市科学技术研究与发展计划资助项目(09130202A-3-35)
关键词 Id1基因 乳腺癌 实时荧光定量逆转录聚合酶链反应 Id1 Breast neoplasms Fluorescent quantitation reverse transcription-polymerase chain reaction
  • 相关文献

参考文献9

  • 1Livak KJ,Sehmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method [J].Methods,2001,25(4) :402-408.
  • 2邢传平,刘斌,董亮.免疫组织化学标记结果的判断方法[J].中华病理学杂志,2001,30(4):318-318. 被引量:206
  • 3Norton JD. ID helix-lop-helix proteins in cell growth, diferenti- ation and tumorigenesis[J]. J Cell Sci, 2001), 113 (Pt22) : 3897-3905.
  • 4Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth[J]. Nat Med,2001,7(11):1194-1201.
  • 5Vandeputte D, Troost D, Leenstra S, et al. Expression and distribution of id hefix-loop-helix proteins in human astrocytic tumors [J]. Glia, 2002,38 (4) : 329-338.
  • 6Gupta GP, Perk J, Acharyya S,et al. ID genes mediate tumor reinitiation during breast cancer lung metastasis[J]. Proc Natl Acad Sci U S A, 2007, 104(49) : 19506-19511.
  • 7Schoppmann SF, Schindl M, Bayer G, et al. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer [J]. Int J Cancer,2003,104(6) : 677-682.
  • 8Manthey C, Mern DS, Gutmann A, et al. Elevated endoge- nous expression of the dominant negative basic helix-loop-helix protein ID1 correlates with significant centrosome abnormali- ties in human tumor cells[J]. BMC Cell Biol, 2010,11.. 2.
  • 9廖妮,唐利立,王泽强,姚志刚,张超杰.OPN和VEGF的表达在乳腺癌复发转移中的意义[J].肿瘤防治研究,2010,37(4):431-434. 被引量:6

二级参考文献16

  • 1杨光,张祥宏,张志刚,王晓玲,王俊灵,严霞,赵俊京,李智岗.乳腺癌钼靶X线表现与癌组织骨桥蛋白、骨连接蛋白表达的相关性研究[J].临床放射学杂志,2006,25(2):134-137. 被引量:21
  • 2郇金亮,王强,邢丽,秦贤举,马旺扣,彭御冰,高志光.乳腺钙化组织中骨桥蛋白的表达及其临床意义[J].中国普通外科杂志,2006,15(4):250-252. 被引量:3
  • 3Zagzag D,Zhong H, Scalzitti JM, et al. Expression of hypoxiainducible factor 1 alpha in brain tumors: association with anglogenesis,invasion, and progression [J]. Cancer, 2000,88 ( 11 ) 2606-2618.
  • 4Weber G F. The metastasis gene osteopontin: a candidate tar get for cancer therapy[J]. Biochim Biophys Acta, 2001,1552 (2) :61-85.
  • 5Denhartdt DT, Guo X. Osteopontin: a protein with diverse functions[J]. FASEB, 1993,7(15) : 1475-1477.
  • 6Shevde LA, Samant RS, Paik JC, et al. Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435[J]. Clin Exp Metastasis, 2006,23 (6) : 123- 133.
  • 7Bramwell V, Doig G, Tuck A, et al. Osteopontin (OPN) : A novel tumor marker of potential utility in metastatic breast cancer [J]. J Clin Oncol,2004, 22(14) :21-22.
  • 8Bellahcene A,Castronovo V. Increased expression of osteonectin and osteopontin, two bone matrix proteins in human breast cancer[J]. Am J Pathol, 1995,146(1) : 95-100.
  • 9Gabriele Carlinfantel, Daphne Vassilioul, Olle Svensson, et al. Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate careinoma[J]. Clin Experi Metast, 2003,20 (8) : 437-444.
  • 10Monica M Reinholz,Stephen J Iturria,James N Ingle, et al. Differential gene expression of TGF-β family members and osteopontin in breast tumor tissue:analysis by real time quantitative PCR[J]. Breast Cancer Res and Trea, 2002,74 ( 15 ): 255- 269.

共引文献210

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部